U.S. Stock News

Mirion Technologies (MIR) shares have climbed 4% after the company posted annual net income growth of 82% on revenue of $902 million. Investors are taking note of this performance, given the solid returns over the past year. See our latest analysis for Mirion Technologies. Momentum has been building for Mirion Technologies, with the share price jumping 21% over the last 90 days and a notable total shareholder return of 64% over the past year. Investors are responding to strong earnings growth...

Xeris Biopharma Holdings recently reported third-quarter 2025 earnings, highlighting revenue growth to US$74.38 million and achieving net income of US$0.62 million, reversing a loss from the prior year. An important insight is that the company also raised its full-year revenue guidance for 2025 to US$285–290 million, signaling expectations of substantial year-on-year growth. To see how the new full-year revenue outlook could influence Xeris Biopharma's outlook, we'll examine its impact on...

Addus HomeCare (ADUS) has seen its stock slide roughly 6% over the past month, continuing a downward trend that started earlier this year. Recent performance is sparking curiosity among investors about the factors shaping the company’s valuation right now. See our latest analysis for Addus HomeCare. Addus HomeCare’s latest 1-month share price return of -5.9% extends what has been a steady year-to-date decline, even as its 1-year total shareholder return sits at -8.9%. With the stock trading...

Earlier this month, Eagle Materials Inc. completed a US$750 million senior notes offering due 2036, raising approximately US$734.9 million in net proceeds to support debt repayment and general corporate purposes. This substantial bond issuance underscores Eagle Materials’ focus on strengthening its liquidity, providing increased flexibility for future investments and financial stability. We’ll examine how this enhanced liquidity position could shape Eagle Materials’ investment narrative and...

Pharvaris recently announced third-quarter 2025 earnings, reporting a net loss of €37.14 million and outlined clinical progress for its hereditary angioedema (HAE) candidate deucrictibant, including long-term safety data and an anticipated pivotal Phase 3 study readout in 2026. The new data presented showed an average 92.4% reduction in HAE attacks over 34 months and highlighted a plasma kinin biomarker assay that may help further characterize bradykinin-mediated angioedema. We’ll explore...

Enterprise Products Partners (EPD) recently completed a substantial fixed-income offering, raising over $300 million through senior unsecured notes at a 4.3% coupon. This move highlights the company's ongoing approach to managing its capital structure and funding strategy. See our latest analysis for Enterprise Products Partners. Enterprise Products Partners' recent completion of its fixed-income offering follows its participation at the Bank of America Global Energy Conference, reflecting...

Norfolk Southern (NSC) shares barely moved today, trading at $283.98 as investors digested recent performance data. With railroad operators facing a shifting demand landscape, the stock’s valuation is drawing some interest among market watchers. See our latest analysis for Norfolk Southern. Norfolk Southern’s latest share price is holding firm after a strong year-to-date run, with a 21.05% gain since January. Its 1-year total shareholder return of 11.02% underscores a steady but moderating...

If you have ever wondered whether USA Rare Earth is a hidden value gem or just another story stock, you are in the right place. The last year saw USA Rare Earth’s share price rise nearly 35.2%. However, it tumbled 16.5% over the past week and is down 57% for the month, showing its risk profile is anything but ordinary. Much of this volatility has been fueled by headlines about supply chain partnerships, new mining exploration licenses, and shifting policies around critical minerals in the...

Canadian Solar reported third-quarter 2025 revenue of US$1.49 billion, exceeding analyst forecasts, alongside a return to net income despite a slight year-over-year sales decline. Recent large-scale energy storage contract wins in Canada, Germany, and Australia highlight momentum in the company’s e-STORAGE segment, with a contracted backlog of US$3.1 billion as of June 2025. We'll consider how Canadian Solar’s strong e-STORAGE results and new contracts could influence its long-term earnings...

Wetteri recently expanded its partnership with Polestar by opening a full-service Polestar store in Kuopio, Finland, offering sales, maintenance, and spare parts, with an official launch on November 6, 2025, and future coverage planned for both Kuopio and Oulu locations. This regional retail expansion coincides with Polestar’s broader efforts to strengthen its European footprint and service network at a time when its operational performance is under increased scrutiny. We'll examine how...

Jacobs, in joint venture with AECOM, announced their appointment by New Murabba Development Company to provide design services for The Mukaab, a landmark centerpiece of Riyadh's New Murabba development and part of Saudi Arabia's Vision 2030 initiative. This collaboration places AECOM at the forefront of one of the largest global urban development projects, reflecting increased demand for sustainable and innovative infrastructure solutions in international markets. We'll examine how AECOM's...

CTS Corporation (CTS) just rolled out a fresh $100 million share repurchase plan with no set expiration, coinciding with the appointment of Kimberly Banks MacKay to the Board. Both moves highlight the company’s active approach to capital allocation and leadership strategy. See our latest analysis for CTS. The fresh $100 million buyback plan and addition of a seasoned board member landed as CTS's share price recovers modestly from its recent lows. Despite a strong 7-day move and a 30-day share...

Sabra Health Care REIT (SBRA) has recently attracted attention as investors dig into its performance over the past month, with the stock advancing almost 6%. This steady upward movement has prompted some investors to revisit their expectations for the real estate investment trust. See our latest analysis for Sabra Health Care REIT. After climbing nearly 6% over the past month, Sabra Health Care REIT is showing signs of renewed momentum, building on a 9% share price return year-to-date and an...

Broadridge Financial Solutions (BR) caught investor attention this week as the company shared results from its latest investor presentation, reaffirmed fiscal 2026 guidance, and announced a continued quarterly cash dividend. Ongoing leadership moves also highlight its ambitions abroad. See our latest analysis for Broadridge Financial Solutions. Broadridge’s recent executive appointment, strong quarterly results, and ongoing buybacks have kept the spotlight on the company; however, the share...

Earlier in November 2025, KeyBanc analyst Philip Gibbs upgraded ATI, highlighting the company's robust performance in core EBITDA margins and anticipated growth in aerospace and defense sales. An interesting dimension is ATI's specialized materials portfolio, which may benefit from increased nuclear sector demand, while its strong free cash flow outlook could support renewed share buybacks. We'll explore how the analyst's recognition of margin strength and free cash flow potential could...

Microsoft recently reported strong quarterly earnings growth, fueled by accelerated demand for Azure and AI-powered cloud services, alongside expanding enterprise adoption of its AI solutions and infrastructure. This performance was further supported by significant investments in new AI data centers, continued momentum around major partnerships, and a robust backlog, underscoring the company's rapidly growing presence in the enterprise AI ecosystem. We'll examine how Microsoft's large-scale...

Pulse Biosciences (PLSE) shares have edged up slightly in recent trading, gaining just under 2% following a stretch of losses this month. The move comes as investors reassess the company’s outlook in light of continued volatility in the healthcare sector. See our latest analysis for Pulse Biosciences. This latest rebound offers a bit of relief for Pulse Biosciences after a tough run that saw the share price slump over the past month. The company’s three-year total shareholder return is still...

Virtus Investment Partners (VRTS) shares have come under pressure over the past month, declining 16%. Investors are taking a closer look at the stock’s trajectory and considering potential catalysts that could shape its direction. See our latest analysis for Virtus Investment Partners. After a tough 30-day stretch for Virtus Investment Partners, with a share price return of -15.5%, the year-to-date slide has extended to -26.1%. Momentum looks decidedly challenged, and the past year’s total...

Earlier this month, Molson Coors Beverage Company reported third-quarter results with sales and revenue declining year-over-year, issued lowered full-year guidance anticipating a 3% to 4% net sales drop, and disclosed large impairment charges totaling over US$3.9 billion. A significant non-cash goodwill impairment led to a net loss for the period, highlighting ongoing operational pressures despite ongoing share buybacks and director share purchases. We'll explore how the recent goodwill...

Borr Drilling Limited recently reported its third quarter 2025 results, posting US$277.1 million in revenue and US$27.8 million in net income, both increasing significantly from the same period last year. An unusually high rig utilization rate and continued contract wins, particularly in markets like Saudi Arabia and Mexico, highlight robust operational momentum for the company. We'll examine how Borr Drilling's increased rig activity and new contract commitments could affect the company's...

DexCom (DXCM) is facing a major legal and regulatory challenge as recent lawsuits claim unauthorized design changes to its G6 and G7 glucose monitors have led to decreased reliability and possible health risks. The FDA has issued a Warning Letter, and these developments have drawn serious attention from both investors and healthcare users. See our latest analysis for DexCom. The regulatory and legal turbulence has clearly fed into DexCom’s share price, which is now down to $58.06 after a...

In recent days, Charles Schwab reported record net new assets of US$44.4 billion in October, with total client assets reaching US$11.83 trillion, alongside a completed US$1 billion fixed-income offering and confirmation of acquiring Forge Global, a private share marketplace, to broaden investor access to private markets. This surge in client engagement, highlighted by a very large year-over-year jump in new account openings, reveals strong operational momentum as Schwab continues to benefit...

Earlier this month, Dave Inc. reported third-quarter 2025 earnings with revenue of US$150.73 million and net income of US$92.07 million, both showing very large increases compared to a year ago, and raised its full-year revenue guidance to US$544 million–US$547 million, up from previous expectations. The company credited its outperformance to higher member monetization driven by a mandatory fee structure and continued product innovation, indicating effective operational changes are...

Curious if Phillips 66 is undervalued or set for a breakout? You're not alone, especially as energy stocks continue to capture investor attention. The stock has shown some serious momentum lately, rising 3.2% in the last week and almost 10% over the last month. It is also up 24.4% year-to-date and 12.8% over the past year. Recent headlines highlight increased refinery utilization rates and strategic investments in renewable fuels, which have boosted market confidence in the company's...